The Lewy Body Dementia Association (LBDA) is proud to present the second webinar of 2024 ‘Move BIG and Speak LOUD with Lewy: The Power of LSVT BIG® and LSVT LOUD® to Optimize Your Quality of Life.’

Hosted by LBDA and LSVT® Global, this webinar explored movement and voice changes associated with #Parkinson’s disease and #Lewybodydementia (LBD) and the evidencebased approaches available to address these changes.

During the session, we discussed how LSVT LOUD® speech therapy enhances communication in daily living; and how LSVT BIG® physical or occupational therapy improves mobility and movement in everyday tasks and activities.

Chapters:
04:50 Introduction with Julia Wood
05:12 Words about LBDA
06:22 Presenters and Panelists
08:17 Disclosures
08:43 Webinar Logistics
09:15 Learning Objectives
11:24 First Presenter (Heather Hodges)
35:53 Second Presenter (Jenny Tuccitto)
1:02:07 Tools to Support Home Practice
1:06:34 How to ask questions
1:22:17 Thank you


Lewy body dementia (LBD) – including both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) – can be challenging to diagnose.

One of the primary challenges has been that there was no laboratory test that could tell during life who had the hallmark brain change associated with LBD. In recent years, though, tremendous progress has been made in developing such tests – which researchers call biomarkers.

In our upcoming webinar, Dr. Kathleen Poston, a leading figure in LBD research and care and colead of the LBDA Research Center of Excellence at Stanford University will discuss the recent advances in the development of biomarkers for alphasynuclein, how they are changing research in LBD, and how they may change clinical practice in the future.

Register today for Introduction to Synuclein Biomarkers: How researchers are “seeing” Lewy bodies in the living brain on Thursday, February 29 at 4:00pm ET at https://us02web.zoom.us/webinar/regis...